Optimization of Fillers in Resin-Based Friction Materials and Analysis of Wear Mechanism Through Orthogonal Design
Abstract
The inherent toxicity of antimony-based fillers in conventional resin-based friction materials necessitates the exploration of sustainable substitutes for wind turbine braking applications. This study therefore aims to formulate a high-performance, environmentally benign alternative using a ternary filler system comprising fly ash microspheres (industrial solid waste), molybdenum disulfide (MoS2), and talc. To optimize the filler proportions, an L9(34) orthogonal array design was implemented, systematically assessing the influence of each component on the friction coefficient, wear rate, and mechanical integrity. Dry sliding wear tests were conducted against an HT250 cast iron disc to simulate operational conditions. The experimental results identify the optimal composition (T3: 6 wt% MoS2, 6 wt% talc, 4 wt% fly ash) as achieving a low wear rate of 0.7 × 10-7 cm3/(N·m) at 350 °C, alongside an 88% recovery rate for the friction coefficient, with these key tribological metrics proving directly comparable to those of traditional antimony-containing formulations. The underlying mechanism for this improved performance lies in the synergistic interaction of the three fillers, which facilitates the development of a stable and cohesive tribofilm on the contact surface. Furthermore, analysis confirms that abrasive wear remains the prevailing material removal mechanism, thereby validating the practical feasibility of this newly developed, non-toxic composite material.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.